An immunomodulating anti-rheumatic drug, lobenzarit disodium (CCA): Inhibition of polyclonal B-cell activation and prevention of autoimmune disease in MRL/Mp-lpr/lpr mice

Clinical Immunology and Immunopathology

Volumn 45, Issue 3, 1987, Pages 366-374

  Mihara, Masahiko ^a   Nakano, Toshiaki ^a   Ohsugi, Yoshiyuki ^a  

^a Chugai Phramaceutical Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LOBENZARIT;

ANIMAL EXPERIMENT; AUTOIMMUNE DISEASE; B LYMPHOCYTE; IMMUNOMODULATION; MOUSE; NONHUMAN;

ADJUVANTS, IMMUNOLOGIC; ANIMAL; ANTHRANILIC ACIDS; ANTIBODIES, ANTINUCLEAR; ANTIGEN-ANTIBODY COMPLEX; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; DNA, SINGLE-STRANDED; IMMUNOGLOBULINS; LONGEVITY; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; MALE; MICE; MICE, MUTANT STRAINS; PROTEINURIA; RHEUMATOID FACTOR; TRINITROBENZENES;

EID: 0023515459     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1016/0090-1229(87)90089-4     Document Type: Article

References (28)